STUELPNAGEL JOHN R sold TXG

September 3, 2026 · Form 4 insider transaction

STUELPNAGEL JOHN R sold 7,012 shares of 10x Genomics, Inc. at $60.66 per share, a transaction worth $425.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Disposed (sell-side)
Shares
7,012
Price
$60.66
Total value
$425.3K
RoleDirector
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2026
Filing dateSeptember 8, 2026
Shares owned after341,424
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction was executed in multiple trades at prices ranging from $60.435 to $61.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

View the original Form 4 on SEC EDGAR
STUELPNAGEL JOHN R sold TXG: September 3, 2026 | Insider Trading Screener